VanEck Pharmaceutical ETF (NASDAQ:PPH) Hits New 52-Week High – What’s Next?

VanEck Pharmaceutical ETF (NASDAQ:PPH) hit a new 52-week high during mid-day trading on Monday . The stock traded as high as $95.58 and last traded at $95.2410, with a volume of 114246 shares changing hands. The stock had previously closed at $93.89.

VanEck Pharmaceutical ETF Price Performance

The company has a market capitalization of $1.18 billion, a P/E ratio of 20.21 and a beta of 0.54. The business has a 50-day moving average of $90.94 and a 200-day moving average of $88.62.

VanEck Pharmaceutical ETF Cuts Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, October 6th. Stockholders of record on Wednesday, October 1st were paid a dividend of $0.3931 per share. The ex-dividend date was Wednesday, October 1st. This represents a $1.57 dividend on an annualized basis and a dividend yield of 1.7%.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of PPH. U.S. Capital Wealth Advisors LLC increased its stake in shares of VanEck Pharmaceutical ETF by 5.8% in the 2nd quarter. U.S. Capital Wealth Advisors LLC now owns 2,750 shares of the company’s stock valued at $242,000 after purchasing an additional 150 shares in the last quarter. Cibc World Market Inc. increased its stake in VanEck Pharmaceutical ETF by 5.1% during the third quarter. Cibc World Market Inc. now owns 4,282 shares of the company’s stock worth $387,000 after purchasing an additional 207 shares during the period. CWM LLC grew its stake in VanEck Pharmaceutical ETF by 167.9% during the 2nd quarter. CWM LLC now owns 375 shares of the company’s stock worth $33,000 after purchasing an additional 235 shares in the last quarter. Creative Financial Designs Inc. ADV lifted its position in shares of VanEck Pharmaceutical ETF by 18.1% during the 2nd quarter. Creative Financial Designs Inc. ADV now owns 2,129 shares of the company’s stock worth $187,000 after purchasing an additional 327 shares during the last quarter. Finally, Jones Financial Companies Lllp lifted its position in shares of VanEck Pharmaceutical ETF by 11.2% during the 3rd quarter. Jones Financial Companies Lllp now owns 3,603 shares of the company’s stock worth $313,000 after buying an additional 363 shares during the last quarter.

About VanEck Pharmaceutical ETF

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.